New target for ALS; Biomarker may help in fight against ovarian cancer; New avenue for schistosomiasis R&D;

> Researchers at Penn Medicine say they discovered that hypermethylation--the epigenetic ability to turn down or turn off a bad gene--serves as a protective barrier inhibiting the development of ALS and frontotemporal degeneration (FTD). Their work, published this month in Neurology, may suggest a neuroprotective target for drug discovery efforts. Release

> Queen's University researcher Madhuri Koti says he has discovered a biomarker that may help lead to better predictions of the success of chemotherapy in ovarian cancer patients. This discovery could lead to better treatment options against ovarian cancer. More

> Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this disease. Release